Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose
The interaction of an antitumoural drug, Epirubicin HCl, with anionic (sodiumdodecylsulfate; SDS), cationic (cetyltrimethylammonium bromide; CTAB), and nonionic (t‐octylphenoxypolyethoxyethanol; TX‐100, polyoxyethylenesorbitanmonolaurate; Tween 20) surfactants has been studied by absorption spectra...
Gespeichert in:
Veröffentlicht in: | Journal of pharmaceutical sciences 2004-06, Vol.93 (6), p.1566-1576 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1576 |
---|---|
container_issue | 6 |
container_start_page | 1566 |
container_title | Journal of pharmaceutical sciences |
container_volume | 93 |
creator | Erdainç, Neşe Göktürk, Si̇nem Tunçay, Melda |
description | The interaction of an antitumoural drug, Epirubicin HCl, with anionic (sodiumdodecylsulfate; SDS), cationic (cetyltrimethylammonium bromide; CTAB), and nonionic (t‐octylphenoxypolyethoxyethanol; TX‐100, polyoxyethylenesorbitanmonolaurate; Tween 20) surfactants has been studied by absorption spectra as a function of surfactant concentration ranging from the premicellar to postmicellar region. At the concentrations below the critical micelle concentration (CMC), the equilibrium complex formation constant between Epirubicin cations and SDS anions has been determined by Job's method. Above the CMC, binding constant (Kb) of Epirubicin to various types of micelles has been calculated by means of the Benesi‐Hildebrand Equation. The nonionic surfactant micelles showed stronger interaction than the ionic SDS micelles, and the binding tendency of Epirubicin followed the order: Tween 20 > TX‐100 > SDS. Binding of Epirubicin also has been studied in the presence of NaCl and glucose because it is administered to patients intravenously in 0.9% NaCl or 5% glucose solution. The additives have been observed to affect the CMC of the surfactants and the Epirubicin–micelle binding constant appreciably. The presence of NaCl and glucose lowered the CMC of all the surfactants studied. The binding constant of Epirubicin decreased in the presence of NaCl but increased in the presence of glucose. The equilibrium complex formation constant between Epirubicin and SDS decreased in the presence of NaCl compared with purely aqueous media. © 2004 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1566–1576, 2004 |
doi_str_mv | 10.1002/jps.20056 |
format | Article |
fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_jps_20056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354916315325</els_id><sourcerecordid>JPS20056</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4336-3a9b7520223517a2eb4ea2fd719be5a181c97f6f0210cd01ec37a13b5ad15f0f3</originalsourceid><addsrcrecordid>eNp10LtOwzAUBmALgWgpDLwAysLAkNaXOG7YoHdUFaSCOlqOYwuXkFR2Sunb45JyGWCyjvydc-wfgHME2whC3FmuXBtDSOMD0EQUwzCGiB2Cpr_DIaFR0gAnzi0hhDGk9Bg0EEU4wihqgrtJUSkrZGXKIih1MFgZu06NNEUw7uXBxlTPwXxttReiqNx1MNBayWpHZ8IDUWTBKF_L0qlTcKRF7tTZ_myBp-HgsTcOp_ejSe9mGsqIkDgkIkmZfyTGhCImsEojJbDOGEpSRQXqIpkwHWuIEZQZREoSJhBJqcgQ1VCTFriq50pbOmeV5itrXoXdcgT5Lg_u8-CfeXh7UdvVOn1V2Y_cB-DB5R4IJ0WurSikcb8cYwljXe86tduYXG3_38jvHuZfq8O6w7hKvX93CPvCY0YY5YvZiM_6t_3housL70ntlc_uzSjLnTSqkCoz1ifOs9L88cEPRHuWPQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Erdainç, Neşe ; Göktürk, Si̇nem ; Tunçay, Melda</creator><creatorcontrib>Erdainç, Neşe ; Göktürk, Si̇nem ; Tunçay, Melda</creatorcontrib><description>The interaction of an antitumoural drug, Epirubicin HCl, with anionic (sodiumdodecylsulfate; SDS), cationic (cetyltrimethylammonium bromide; CTAB), and nonionic (t‐octylphenoxypolyethoxyethanol; TX‐100, polyoxyethylenesorbitanmonolaurate; Tween 20) surfactants has been studied by absorption spectra as a function of surfactant concentration ranging from the premicellar to postmicellar region. At the concentrations below the critical micelle concentration (CMC), the equilibrium complex formation constant between Epirubicin cations and SDS anions has been determined by Job's method. Above the CMC, binding constant (Kb) of Epirubicin to various types of micelles has been calculated by means of the Benesi‐Hildebrand Equation. The nonionic surfactant micelles showed stronger interaction than the ionic SDS micelles, and the binding tendency of Epirubicin followed the order: Tween 20 > TX‐100 > SDS. Binding of Epirubicin also has been studied in the presence of NaCl and glucose because it is administered to patients intravenously in 0.9% NaCl or 5% glucose solution. The additives have been observed to affect the CMC of the surfactants and the Epirubicin–micelle binding constant appreciably. The presence of NaCl and glucose lowered the CMC of all the surfactants studied. The binding constant of Epirubicin decreased in the presence of NaCl but increased in the presence of glucose. The equilibrium complex formation constant between Epirubicin and SDS decreased in the presence of NaCl compared with purely aqueous media. © 2004 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1566–1576, 2004</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.20056</identifier><identifier>PMID: 15124214</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Hoboken: Elsevier Inc</publisher><subject>binding constant ; Biological and medical sciences ; Drug Interactions ; Epirubicin - analysis ; Epirubicin - chemistry ; Epirubicin - metabolism ; Epirubicin HCl ; General pharmacology ; glucose ; Glucose - analysis ; Glucose - metabolism ; interaction ; Job's method ; Medical sciences ; NaCl ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; SDS ; Sodium Chloride - analysis ; Sodium Chloride - metabolism ; Surface-Active Agents - analysis ; Surface-Active Agents - metabolism ; surfactants ; Tween 20 ; TX100</subject><ispartof>Journal of pharmaceutical sciences, 2004-06, Vol.93 (6), p.1566-1576</ispartof><rights>2004 Wiley-Liss, Inc.</rights><rights>Copyright © 2004 Wiley‐Liss, Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1566-1576, 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4336-3a9b7520223517a2eb4ea2fd719be5a181c97f6f0210cd01ec37a13b5ad15f0f3</citedby><cites>FETCH-LOGICAL-c4336-3a9b7520223517a2eb4ea2fd719be5a181c97f6f0210cd01ec37a13b5ad15f0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.20056$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.20056$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15779778$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15124214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Erdainç, Neşe</creatorcontrib><creatorcontrib>Göktürk, Si̇nem</creatorcontrib><creatorcontrib>Tunçay, Melda</creatorcontrib><title>Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>The interaction of an antitumoural drug, Epirubicin HCl, with anionic (sodiumdodecylsulfate; SDS), cationic (cetyltrimethylammonium bromide; CTAB), and nonionic (t‐octylphenoxypolyethoxyethanol; TX‐100, polyoxyethylenesorbitanmonolaurate; Tween 20) surfactants has been studied by absorption spectra as a function of surfactant concentration ranging from the premicellar to postmicellar region. At the concentrations below the critical micelle concentration (CMC), the equilibrium complex formation constant between Epirubicin cations and SDS anions has been determined by Job's method. Above the CMC, binding constant (Kb) of Epirubicin to various types of micelles has been calculated by means of the Benesi‐Hildebrand Equation. The nonionic surfactant micelles showed stronger interaction than the ionic SDS micelles, and the binding tendency of Epirubicin followed the order: Tween 20 > TX‐100 > SDS. Binding of Epirubicin also has been studied in the presence of NaCl and glucose because it is administered to patients intravenously in 0.9% NaCl or 5% glucose solution. The additives have been observed to affect the CMC of the surfactants and the Epirubicin–micelle binding constant appreciably. The presence of NaCl and glucose lowered the CMC of all the surfactants studied. The binding constant of Epirubicin decreased in the presence of NaCl but increased in the presence of glucose. The equilibrium complex formation constant between Epirubicin and SDS decreased in the presence of NaCl compared with purely aqueous media. © 2004 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1566–1576, 2004</description><subject>binding constant</subject><subject>Biological and medical sciences</subject><subject>Drug Interactions</subject><subject>Epirubicin - analysis</subject><subject>Epirubicin - chemistry</subject><subject>Epirubicin - metabolism</subject><subject>Epirubicin HCl</subject><subject>General pharmacology</subject><subject>glucose</subject><subject>Glucose - analysis</subject><subject>Glucose - metabolism</subject><subject>interaction</subject><subject>Job's method</subject><subject>Medical sciences</subject><subject>NaCl</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>SDS</subject><subject>Sodium Chloride - analysis</subject><subject>Sodium Chloride - metabolism</subject><subject>Surface-Active Agents - analysis</subject><subject>Surface-Active Agents - metabolism</subject><subject>surfactants</subject><subject>Tween 20</subject><subject>TX100</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10LtOwzAUBmALgWgpDLwAysLAkNaXOG7YoHdUFaSCOlqOYwuXkFR2Sunb45JyGWCyjvydc-wfgHME2whC3FmuXBtDSOMD0EQUwzCGiB2Cpr_DIaFR0gAnzi0hhDGk9Bg0EEU4wihqgrtJUSkrZGXKIih1MFgZu06NNEUw7uXBxlTPwXxttReiqNx1MNBayWpHZ8IDUWTBKF_L0qlTcKRF7tTZ_myBp-HgsTcOp_ejSe9mGsqIkDgkIkmZfyTGhCImsEojJbDOGEpSRQXqIpkwHWuIEZQZREoSJhBJqcgQ1VCTFriq50pbOmeV5itrXoXdcgT5Lg_u8-CfeXh7UdvVOn1V2Y_cB-DB5R4IJ0WurSikcb8cYwljXe86tduYXG3_38jvHuZfq8O6w7hKvX93CPvCY0YY5YvZiM_6t_3housL70ntlc_uzSjLnTSqkCoz1ifOs9L88cEPRHuWPQ</recordid><startdate>200406</startdate><enddate>200406</enddate><creator>Erdainç, Neşe</creator><creator>Göktürk, Si̇nem</creator><creator>Tunçay, Melda</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200406</creationdate><title>Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose</title><author>Erdainç, Neşe ; Göktürk, Si̇nem ; Tunçay, Melda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4336-3a9b7520223517a2eb4ea2fd719be5a181c97f6f0210cd01ec37a13b5ad15f0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>binding constant</topic><topic>Biological and medical sciences</topic><topic>Drug Interactions</topic><topic>Epirubicin - analysis</topic><topic>Epirubicin - chemistry</topic><topic>Epirubicin - metabolism</topic><topic>Epirubicin HCl</topic><topic>General pharmacology</topic><topic>glucose</topic><topic>Glucose - analysis</topic><topic>Glucose - metabolism</topic><topic>interaction</topic><topic>Job's method</topic><topic>Medical sciences</topic><topic>NaCl</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>SDS</topic><topic>Sodium Chloride - analysis</topic><topic>Sodium Chloride - metabolism</topic><topic>Surface-Active Agents - analysis</topic><topic>Surface-Active Agents - metabolism</topic><topic>surfactants</topic><topic>Tween 20</topic><topic>TX100</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Erdainç, Neşe</creatorcontrib><creatorcontrib>Göktürk, Si̇nem</creatorcontrib><creatorcontrib>Tunçay, Melda</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Erdainç, Neşe</au><au>Göktürk, Si̇nem</au><au>Tunçay, Melda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>2004-06</date><risdate>2004</risdate><volume>93</volume><issue>6</issue><spage>1566</spage><epage>1576</epage><pages>1566-1576</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>The interaction of an antitumoural drug, Epirubicin HCl, with anionic (sodiumdodecylsulfate; SDS), cationic (cetyltrimethylammonium bromide; CTAB), and nonionic (t‐octylphenoxypolyethoxyethanol; TX‐100, polyoxyethylenesorbitanmonolaurate; Tween 20) surfactants has been studied by absorption spectra as a function of surfactant concentration ranging from the premicellar to postmicellar region. At the concentrations below the critical micelle concentration (CMC), the equilibrium complex formation constant between Epirubicin cations and SDS anions has been determined by Job's method. Above the CMC, binding constant (Kb) of Epirubicin to various types of micelles has been calculated by means of the Benesi‐Hildebrand Equation. The nonionic surfactant micelles showed stronger interaction than the ionic SDS micelles, and the binding tendency of Epirubicin followed the order: Tween 20 > TX‐100 > SDS. Binding of Epirubicin also has been studied in the presence of NaCl and glucose because it is administered to patients intravenously in 0.9% NaCl or 5% glucose solution. The additives have been observed to affect the CMC of the surfactants and the Epirubicin–micelle binding constant appreciably. The presence of NaCl and glucose lowered the CMC of all the surfactants studied. The binding constant of Epirubicin decreased in the presence of NaCl but increased in the presence of glucose. The equilibrium complex formation constant between Epirubicin and SDS decreased in the presence of NaCl compared with purely aqueous media. © 2004 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1566–1576, 2004</abstract><cop>Hoboken</cop><pub>Elsevier Inc</pub><pmid>15124214</pmid><doi>10.1002/jps.20056</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3549 |
ispartof | Journal of pharmaceutical sciences, 2004-06, Vol.93 (6), p.1566-1576 |
issn | 0022-3549 1520-6017 |
language | eng |
recordid | cdi_crossref_primary_10_1002_jps_20056 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection |
subjects | binding constant Biological and medical sciences Drug Interactions Epirubicin - analysis Epirubicin - chemistry Epirubicin - metabolism Epirubicin HCl General pharmacology glucose Glucose - analysis Glucose - metabolism interaction Job's method Medical sciences NaCl Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments SDS Sodium Chloride - analysis Sodium Chloride - metabolism Surface-Active Agents - analysis Surface-Active Agents - metabolism surfactants Tween 20 TX100 |
title | Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T18%3A08%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20of%20Epirubicin%20HCl%20with%20Surfactants:%20Effect%20of%20NaCl%20and%20Glucose&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Erdain%C3%A7,%20Ne%C5%9Fe&rft.date=2004-06&rft.volume=93&rft.issue=6&rft.spage=1566&rft.epage=1576&rft.pages=1566-1576&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.20056&rft_dat=%3Cwiley_cross%3EJPS20056%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15124214&rft_els_id=S0022354916315325&rfr_iscdi=true |